Management of Patients with Newly Diagnosed Desmoid Tumors in a First-Line Setting.
Ontology highlight
ABSTRACT: The initial management of desmoid tumors (DTs) is shifting from surgery towards active surveillance, with systemic and locally ablative treatments reserved for enlarging and/or symptomatic disease. However, it remains unclear which patients would benefit most from an initial conservative rather than interventional approach. To answer this question, we retrospectively analyzed adult and pediatric patients with DTs treated at a tertiary academic cancer center between 1992 and 2022. Outcomes measured were progression-free survival (PFS) and time to next treatment (TTNT) after first-line therapy. A total of 262 treatment-naïve patients were eligible for analysis with a median age of 36.5 years (range, 0-87 years). The 5-year PFS and the median TTNT (months) after first-line treatment were, res
SUBMITTER: Testa S
PROVIDER: S-EPMC9405618 | biostudies-literature | 2022 Aug
REPOSITORIES: biostudies-literature
ACCESS DATA